Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease

@article{Vaziri2013RoleOD,
  title={Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease},
  author={Nosratola D. Vaziri},
  journal={Clinical and Experimental Nephrology},
  year={2013},
  volume={18},
  pages={265-268}
}
Advanced chronic kidney disease (CKD) results in a constellation of dysregulation of lipid metabolism, oxidative stress, and inflammation which are causally interconnected and participate in a vicious cycle. The CKD-associated lipid disorders are marked by impaired clearance of very low density lipoprotein and chylomicrons, hypertriglyceridemia, formation of small dense low-density lipoprotein (LDL), oxidative modification of LDL, intermediate density lipoprotein and chylomicron remnants, and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 46 references

Lipoprotein lipase deficiency in chronic kidney disease is compounded by downregulation of endothelial GPIHBP1 expression

ND Vaziri, J Yuan, Z Ni, SB Nicholas, KC. Norris
Clin Exp Nephrol • 2012
View 3 Excerpts
Highly Influenced

Post-transcriptional nature of uremia-induced downregulation of hepatic apolipoprotein A-I production.

Translational research : the journal of laboratory and clinical medicine • 2013
View 2 Excerpts

Dysfunctional high-density lipoprotein in patients on chronic hemodialysis.

Journal of the American College of Cardiology • 2012
View 1 Excerpt

New insights into lipid metabolism in chronic kidney disease.

Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation • 2011

Similar Papers

Loading similar papers…